Back
Arcus Biosciences, Inc. 10K Form
Sell
38
RCUS
Arcus Biosciences, Inc.
Last Price:
$25.10
Seasonality Move:
6.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RCUS News And Ratings
See the #1 stock for the next 7 days that we like better than RCUS
RCUS Financial Statistics
Sales & Book Value
| Annual Sales: | $258M |
|---|---|
| Cash Flow: | $-97M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.07 |
| Price / Book: | 7.17 |
Profitability
| EPS (TTM): | -3.43090 |
|---|---|
| Net Income (TTM): | $-341M |
| Gross Margin: | $248M |
| Return on Equity: | -66.45% |
| Return on Assets: | -30.41% |
Arcus Biosciences, Inc. Earnings Forecast
Key Arcus Biosciences, Inc. Financial Ratios
-
The Gross Profit Margin over the past 9 years for RCUS is 96.12%.
-
The Selling, General & Administrative Expenses for RCUS have been equal to 46.51% of Gross Profit Margin.
-
The Research & Development expenses have been 173.64% of Revenue.
-
The Net Earning history of RCUS is -109.69% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 2 years.
Arcus Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RCUS |
| CUSIP: | 03969F |
| Website: | arcusbio.com |
Debt
| Debt-to-Equity Ratio: | 0.25 |
|---|---|
| Current Ratio: | 3.65 |
| Quick Ratio: | 3.58 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
RCUS Technical Analysis vs Fundamental Analysis
Sell
38
Arcus Biosciences, Inc. (RCUS)
is a Sell
Is Arcus Biosciences, Inc. a Buy or a Sell?
-
Arcus Biosciences, Inc. stock is rated a SellThe current Arcus Biosciences, Inc. [RCUS] share price is $25.26. The Score for RCUS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.